Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olopatadine nasal spray versus mometasone nasal spray for allergic rhinosinusitis
IRCT20200727048222N1Phase 3Completed
- Sponsor
- Sabzevar University of Medical Sciences
- Start
- Aug 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in allergic rhinosinusitis comparing Olopatadine nasal spray with Mometasone nasal spray (2 arms). Primary endpoints: Response to treatment and Patient satisfaction. Started Aug 2020; status: completed.
02
Drugs
olopatadinemometasone
03
Conditions
allergic rhinosinusitis
Beyond the preview
Go deeper on IRCT20200727048222N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200727048222N1.